Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation
10.1136/bmjopen-2018-025333
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246034 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-246034 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2460342023-11-17T08:18:52Z Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation Khandaker, GM Oltean, BP Kaser, M Dibben, CRM Ramana, R Jadon, DR Dantzer, R Coles, AJ Lewis, G Jones, PB DEPT OF PSYCHOLOGICAL MEDICINE clinical trials Antibodies, Monoclonal, Humanized Biomarkers C-Reactive Protein Cognition Depressive Disorder Double-Blind Method Humans Inflammation Infusions, Intravenous Proof of Concept Study Psychiatric Status Rating Scales Randomized Controlled Trials as Topic Receptors, Interleukin-6 Treatment Outcome 10.1136/bmjopen-2018-025333 BMJ Open 8 9 e025333- 2023-11-17T08:04:16Z 2023-11-17T08:04:16Z 2018-01-01 2023-11-17T05:20:18Z Article Khandaker, GM, Oltean, BP, Kaser, M, Dibben, CRM, Ramana, R, Jadon, DR, Dantzer, R, Coles, AJ, Lewis, G, Jones, PB (2018-01-01). Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 8 (9) : e025333-. ScholarBank@NUS Repository. https://doi.org/10.1136/bmjopen-2018-025333 2044-6055 https://scholarbank.nus.edu.sg/handle/10635/246034 Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
clinical trials Antibodies, Monoclonal, Humanized Biomarkers C-Reactive Protein Cognition Depressive Disorder Double-Blind Method Humans Inflammation Infusions, Intravenous Proof of Concept Study Psychiatric Status Rating Scales Randomized Controlled Trials as Topic Receptors, Interleukin-6 Treatment Outcome |
spellingShingle |
clinical trials Antibodies, Monoclonal, Humanized Biomarkers C-Reactive Protein Cognition Depressive Disorder Double-Blind Method Humans Inflammation Infusions, Intravenous Proof of Concept Study Psychiatric Status Rating Scales Randomized Controlled Trials as Topic Receptors, Interleukin-6 Treatment Outcome Khandaker, GM Oltean, BP Kaser, M Dibben, CRM Ramana, R Jadon, DR Dantzer, R Coles, AJ Lewis, G Jones, PB Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
description |
10.1136/bmjopen-2018-025333 |
author2 |
DEPT OF PSYCHOLOGICAL MEDICINE |
author_facet |
DEPT OF PSYCHOLOGICAL MEDICINE Khandaker, GM Oltean, BP Kaser, M Dibben, CRM Ramana, R Jadon, DR Dantzer, R Coles, AJ Lewis, G Jones, PB |
format |
Article |
author |
Khandaker, GM Oltean, BP Kaser, M Dibben, CRM Ramana, R Jadon, DR Dantzer, R Coles, AJ Lewis, G Jones, PB |
author_sort |
Khandaker, GM |
title |
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
title_short |
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
title_full |
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
title_fullStr |
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
title_full_unstemmed |
Protocol for the insight study: A randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
title_sort |
protocol for the insight study: a randomised controlled trial of singledose tocilizumab in patients with depression and low-grade inflammation |
publishDate |
2023 |
url |
https://scholarbank.nus.edu.sg/handle/10635/246034 |
_version_ |
1783955468184453120 |